Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients (original) (raw)
Related papers
Pain Medicine, 2011
Background. Painful vertebral compression fractures (VCFs), whether pathologic or osteoporotic, are a source of morbidity in cancer patients. At our tertiary cancer center, over the past decade we have used vertebroplasty (VP) and kyphoplasty (KP) to treat painful VCFs. More data are needed on the treatment of VCFs in cancer patients with these techniques. Methods. We retrospectively reviewed the medical records of cancer patients with painful VCFs that had been treated at our institution between January 1, 2001 and May 31, 2008. Information was collected on demographic and clinical characteristics, features of the fractures, procedural details, and complications. Pre-and post-procedural pain and related symptoms were assessed using a subset of patients who had responded to the Brief Pain Inventory and the Edmonton Symptom Assessment Scale. Results. A total of 407 cancer patients had 1,156 fractures that had been treated with VP or KP during 536 surgical procedures. Patients had an average of 2.8 fractures (range, 1-10). The majority of patients had pathologic fractures due to multiple myeloma (43%) or osteoporotic fractures (35%). Most fractures occurred in the thoracolumbar region. Adjacent-level fractures occurred in 18% of patients. Surgery provided significant relief from pain and several related symptoms. Symptomatic, serious complications requiring open surgery occurred in two cases (<0.01%) in our series. Conclusions. Our single-center experience revealed that a large number of cancer patients suffer from painful VCFs. The use of VP or KP in treating painful VCFs in cancer patients has good efficacy and an acceptably low complication rate.
Vertebroplasty and Kyphoplasty for the Palliation of Pain
Seminars in Interventional Radiology, 2007
Vertebroplasty and kyphoplasty are percutaneous techniques developed over the past 20 years to treat vertebral hemangiomas, osteoporotic compression fractures, and osteolytic tumors of the spine. In carefully selected patients, these procedures have led to the cessation or significant reduction in pain in 80 to 90% of patients. In this article, we review the indications and contraindications of these procedures, appropriate patient selection and evaluation, the technique, outcomes, and the potential complications of this form of therapy when performed for the alleviation of pain for osteolytic tumors of the spine.
Percutaneous vertebroplasty is safe and effective for cancer-related vertebral compression fractures
2018
INTRODUCTION In cancer patients with painful vertebral fractures due to spinal metastasis, traditional pain-relieving therapies include analgesics, bed rest, steroids, radio-ther-apy, etc. These treatment modalities are often ineffective. Traditional spinal surgery in general anaesthesia is usually not an option in patients with advanced cancer and in a poor general condition. Percutaneous vertebroplasty (PVP) has been reported as a minimally invasive treatment option with apparent rapid pain relief compared with other conventional treatment options. The objective of this study was to assess the safety and efficacy of PVP in patients with malignant spinal lesions. METHODS From the National Danish Surgical Spine Database, DaneSpine, 30 consecutive cancer patients with vertebral fractures who underwent PVP from 2013 to 2017 were identified. From DaneSpine, the European Quality of Life - 5 Dimensions Questionnaire (EQ-5D) and the Oswestry Disability Index (ODI) scores were collected pr...
Effectiveness of percutaneous vertebroplasty in patients with multiple myeloma having vertebral pain
Diagnostic and Interventional Radiology, 2016
ultiple myeloma (MM) is a hematologic malignancy characterized by lytic bone lesions and is usually with vertebral involvement. At the time of diagnosis, vertebral involvement is present in approximately 60% of patients (1). Pathologic vertebral fractures can easily occur in MM. Spinal instability, back pain, neurologic dysfunction and physical symptoms can be observed in patients with MM due to vertebral fractures. As a result, the quality of life of patients is affected significantly. A variety of contemporary therapeutic approaches are available for vertebral involvement in MM. These approaches are chemotherapy, radiotherapy, radioisotope therapy, bisphosphonate therapy, algological treatment and palliative/stabilization surgery. Risks of spinal instability and neural compression can be high with conservative treatment options. While surgery can be suitable for patients with neural compression, its complication rates are high (2). Percutaneous vertebroplasty (PV) is a minimally invasive treatment method. PV is used to treat back pain caused by vertebral involvement due to osteoporotic vertebral compression fractures, metastasis, multiple myeloma, and aggressive hemangioma (3). PV increases spinal stability by preventing vertebral collapse (2). PV was originally used for treatment of painful vertebral hemangioma by Galibert et al. (4). In several studies, it was reported that PV prevented vertebral height loss and reduced patient pain and need of analgesia use in patients with vertebral involvement due to osteoporosis and metastasis (5-8). PV usage is gradually increasing for vertebral involvement due to MM. However, data on PV usage for MM is limited in the literature (8). PV is preferred because it is more easily performed than surgery, more effective, and has lower rates of serious complications. The aim of this study was to assess the effectiveness, benefits, and reliability of PV in patients with vertebral involvement of MM.
Journal of Clinical Neuroscience, 2010
Kyphoplasty is a minimally invasive procedure that is used to augment vertebral body strength. This technique has been commonly used to treat osteoporotic, vertebral body compression fractures. The technique was also used to augment painful metastatic vertebral fractures. The objective of this study was to review the clinical and radiological results after kyphoplasty in patients with vertebral body compression fractures due to spinal metastasis and multiple myeloma and to determine factors that may affect outcome. Thirty-one patients had 41 vertebral body fractures secondary to spinal metastasis or multiple myeloma. A kyphoplasty procedure was performed on 39 levels. The pain and neurological status were evaluated using the visual analogue scale (VAS) score and the American Spinal Injury Association classification scale scores, respectively. Radiological evaluations were used to measure vertebral body height loss (VBHL) and the segmental kyphosis angle before and after surgery. The major symptoms that patients presented with included pain (25 patients); and neurological deficit (four patients). Two patients presented with no symptoms because the metastases were found during cancer screening. The mean (±standard deviation [SD]) VAS score was 7.2 ± 2.2 before surgery and 1.6 ± 1.3 after surgery. The mean preoperative VBHL was 27.8 ± 11.3% for the thoracic spine and 27.7 ± 12.5% for the lumbar spine. VBHL values were reduced to 22.4 ± 10.0% and 18.4 ± 10.4% for the thoracic and lumbar spine after surgery, respectively. The segmental kyphosis angles decreased from 21.2 ± 11.4°to 17.0 ± 9.8°for the thoracic spine and from 15.3 ± 8.8°to 10.4 ± 7.2°for the lumbar spine after surgery. There was a correlation between the symptom duration and VBH restoration rate. There was no correlation between the amount of injected polymethylmethacrylate and pain relief. We concluded that kyphoplasty is a safe and effective procedure for treating painful vertebral body fractures caused by metastasis and multiple myeloma. It can restore VBH and correct the kyphosis angle. While the increased amount of the injected PMMA led to its leakage, it did not contribute to restoration of the VBH or kyphosis correction. Therefore, one should avoid injection of excessive amounts of PMMA.